Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 24/12/12

Trade details

Type: Insider sale
Amount: $241,855.45
Shares · price: 7,855 sh · $30.79 a share
Held after: 597,562 sh
Stock: Akero Therapeutics AKRO
Person: Andrew ChengPresident and CEO
Trade date: 24/12/10
Filed: 24/12/12
Days to filing: 2 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/10~25/01/09

Andrew Cheng's recent trades

Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1.6M
30,000 sh
$1.6M
Filed 25/10/14
Traded 25/10/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$968.3K
22,525 sh
$968.3K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$321.9K
7,317 sh
$321.9K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$77.3K
1,796 sh
$77.3K
Filed 25/09/12
Traded 25/09/11
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$7,050
158 sh
$7,050
Filed 25/09/12
Traded 25/09/10